Business Context and Reporting Period
Company: Spruce Biosciences, Inc. (SPRB)
Filing Type: Form 8-K (Current Report)
Date of Report: March 31, 2025
Context: The Company filed a Notification of Late Filing on Form 12b-25 with the SEC regarding its Annual Report on Form 10-K for the fiscal year ended December 31, 2024.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The 8-K references a Form 12b-25 (Exhibit 99.1) which contains "certain estimates" regarding the fiscal year 2024 results, but the specific figures are not included in the provided text.
Material Changes
No material changes to financial performance or operations are detailed in this specific filing text. The primary event reported is the administrative delay in filing the annual report for the fiscal year ended December 31, 2024.
Guidance, Outlook, and Risks
- Management Commentary: The filing states that the information regarding the late filing and the referenced estimates shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
- Risks/Contingencies: The filing highlights a regulatory contingency: the failure to file the Form 10-K by the statutory deadline, necessitating the Form 12b-25 notification.
Investor Verification Checklist
- Verify the specific estimated financial figures for the fiscal year ended December 31, 2024, by reviewing the attached Form 12b-25 (Exhibit 99.1).
- Confirm the expected filing date for the delayed Form 10-K.
- Review the reasons for the late filing to assess potential internal control or operational issues.
- Monitor for any subsequent 8-K filings that may update the financial estimates or provide the final audited results.